{"id": "1386190845968224260", "creation": 1619328626.0, "user_id": "303862998", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 82, "reply_count": 2, "like_count": 76, "quote_count": 15}}, "text": "China's #Sinopharm has commenced phase-1 and phase-2 clinical trials for its new recombinant #vaccine against #COVID19 in C China's Henan Province since Saturday. The vaccine was issued with a clinical research permit from the National Medical Products Administration on April 9. https://t.co/PK7qv7Vk8n", "first_save": 1634559108.199414, "hashtags": ["#SINOPHARM", "#VACCINE", "#COVID19"]}